
About Pragna Group
Pragna Group is a Healthcare company based in India founded in 2017. It manufactures and exports high-quality speciality chemicals, agro intermediates, dyes intermediates, and API intermediates globally. It operates on a B2B model in Healthcare and Chemicals & Materials sectors. The company has 43 employees. Its Indian entity Pragna Life Science Private Limited reported revenue of βΉ12.46 Cr. Pragna Group offers products and services including Speciality Chemicals & Agro Intermediates, Dyes Intermediates, and API Intermediates. Its focus areas include Chemicals, API Intermediates, Pharmaceutical and API.
Company details
Pragna Group, established in 1999 and promoted by trade experts, is a leading manufacturer and exporter of high-quality intermediates for speciality chemicals, agro chemicals, dyes, and API. Operating from manufacturing facilities in Ankleshwar, India, with a marketing office in Canada, they emphasize safety, environmental compliance, and quality standards. They serve global clients through reliable production and transparent business practices, focusing on custom synthesis and toll manufacturing.
- Headquarters India
- Employees 43
- SectorsHealthcareChemicals & Materials
- Emailβ’β’β’β’β’β’β’β’
- Website pragna-group.com
- Social LinkedIn Instagram
- Legal Name Pragna Life Science Private Limited
- Date of Incorporation 26 Jun, 2012
- Jurisdiction Ankleshwar, Gujarat, India
- Annual Revenue₹12.46 Cr
FY 2024 · +2% YoY
- Net Profit₹89.5 Lakh
FY 2024 · 7% margin
- EBITDA₹2.28 Cr
FY 2024 · 18% margin
- Employee Count43
Associated legal entities of Pragna Group
Pragna Group operates through Pragna Life Science Private Limited (converted to llp). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Pragna Life Science Private Limited CIN U24239GJ2012PTC070925 | Converted To Llp | 26 Jun 2012 | Ankleshwar, Gujarat | ₹12.5 Cr | 43 | 4 | View details |
Products & Services of Pragna Group
Pragna Group offers a comprehensive portfolio of products and services, including Speciality Chemicals & Agro Intermediates, Dyes Intermediates, and API Intermediates.
Intermediates for production of speciality and agro chemicals
Raw materials used in dyes manufacturing processes
Intermediates for active pharmaceutical ingredients development
Board of directors of Pragna Life Science Private Limited (Pragna Group)
Pragna Life Science Private Limited is the primary company behind Pragna Group. The board of Pragna Life Science Private Limited currently have 4 directors; the longest-serving is Jigneshkumar Kalidas Patel, appointed in 2012. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jigneshkumar Kalidas Patel DIN 05268889 | Director | 26 Jun 2012 | 14 yrs 3 mo | Pragna Life Science Private Limited |
| Dipakkumar Shankarlal Patel DIN 06444940 | Director | 04 Feb 2014 | 12 yrs 8 mo | Pragna Life Science Private Limited |
| Chiragkumar Ambalal Patel DIN 08718606 | Director | 20 Aug 2020 | 6 yrs 2 mo | Pragna Life Science Private Limited |
| Maheshkumar Jivanlal Patel DIN 00632466 | Additional Director | 21 Feb 2025 | 1 yr 7 mo | Pragna Life Science Private Limited |
Financials of Pragna Group
Figures of Pragna Life Science Private Limited, the primary company behind Pragna Group, for FY 2024. Revenue was ₹12.46 Cr (+2% year on year). Net profit was ₹89.5 Lakh (7% margin). EBITDA was ₹2.28 Cr (18% margin). Revenue has grown at a compounded annual rate of -14% over three years and -2% over five years.
- ₹12.46 CrRevenue · FY 2024 · +2% YoY
- ₹89.5 LakhNet profit · 7% margin
- ₹2.28 CrEBITDA · 18% margin
- ₹1.00 CrPaid-up capital
- 43Employees (provident fund records)
- -14%Revenue CAGR, 3 years
- -2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Pragna Life Science Private Limited are on its company page.
Detailed financial statements for Pragna Group
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Pragna Group (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pragna Group
Pragna Group was founded in 2017.
Pragna Group is headquartered in India.
Pragna Group has 43 employees.
The primary company behind Pragna Group, Pragna Life Science Private Limited, reported revenue of βΉ12.46 Cr for FY 2024, up 2% year on year.
Pragna Group, established in 1999 and promoted by trade experts, is a leading manufacturer and exporter of high-quality intermediates for speciality chemicals, agro chemicals, dyes, and API. Operating from manufacturing facilities in Ankleshwar, India, with a marketing office in Canada, they emphasize safety, environmental compliance, and quality standards. They serve global clients through reliable production and transparent business practices, focusing on custom synthesis and toll manufacturing.
Pragna Group offers Speciality Chemicals & Agro Intermediates, Dyes Intermediates, and API Intermediates.
Pragna Group operates through Pragna Life Science Private Limited.
The legal entities of Pragna Group currently have 4 directors, including Maheshkumar Jivanlal Patel, Dipakkumar Shankarlal Patel, Jigneshkumar Kalidas Patel and others.